Guardant Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Guardant Health, Inc. on February 24, 2020. The filing primarily serves to announce the Company's financial results for the fiscal quarter and full year ended December 31, 2019, and to disclose a significant executive departure.
Key Financial Metrics
The filing text references a press release (Exhibit 99.1) containing the specific financial results for the quarter and year ended December 31, 2019. However, the body of this 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the incorporated press release for these figures.
Material Changes and Corporate Events
- Executive Departure: Derek Bertocci, the Company's Chief Financial Officer (CFO), notified the Company on February 24, 2020, of his intention to retire during the second quarter of 2020.
- Succession Plan: The Company has initiated a search for a new CFO. Mr. Bertocci will remain in his current role to facilitate an orderly transition until a successor is hired.
Guidance, Outlook, and Risks
The filing does not contain specific forward-looking guidance, management commentary on future performance, or a detailed discussion of risks and contingencies within the text provided. The primary risk disclosed is the transition of the CFO role, which the Company is managing through an interim retention of the outgoing officer.
Key Facts for Investor Verification
- Verify the specific revenue and net loss figures for Q4 and Full Year 2019 in the press release (Exhibit 99.1) referenced in this filing.
- Monitor the timeline for the appointment of a new CFO to ensure the transition occurs within the projected second quarter of 2020.
- Review the full text of the press release for any updated guidance or strategic shifts not detailed in this summary report.